Ondansetron for Prevention of Post-Operative Nausea and Vomiting (PONV) in General Surgery Patients

Muhammad Naeem

Department of Anesthesiology, SICU and Pain Center, PUMHS, Pakistan.

Rafia Tabassum

Department of Anesthesiology, SICU and Pain Center, PUMHS, Pakistan.

Muhammad Saleh Khaskheli

Department of Anesthesiology, SICU and Pain Center, PUMHS, Pakistan.

Aijaz Hussain Awan

Department of Anesthesiology, SICU and Pain Center, PUMHS, Pakistan.

Munazzah Meraj

Department of Biochemistry, IPRS, PUMHSW, Pakistan.

Rao Irfan *

Pharmaceutical Sciences, IPS, PUMHS Pakistan.

*Author to whom correspondence should be addressed.


Abstract

Aim: To determine the efficacy of single dose ondansetron in preventing PONV in patients.

Methodology: In this cross sectional study 49 patients were given Ondansetron.  Every patient was evaluated for PONV at 1, 2, 3, 6, 12 and 24 hours post operatively. This study was conducted at General surgery operation theatres and surgical wards I, II, III and Department of Anesthesia and SICU Peoples University of Medical & Health Sciences for women Nawabshah, District Shaheed Benazirabad, Sindh.

Results: A sample of 49 patients with age between 20-60 years (mean age 43.72±5.67 years), 35% male and 65% female was included in this study. In this study ondansetron was given (N=49) 4 mg I/V before induction. Regarding complications there was not significant (p ≤0.05) POVN was observed.

Conclusion: Our study results showed in patients who received ondansetron regarding frequency of post operative complications (PONV) showed insignificant results as no p-value is found to be ≤0.05.It was concluded that a single dose of ondansetron is very effective in preventing PONV in general surgery patients.

Keywords: Efficacy, postoperative nausea and vomiting, PONV, ondansetron


How to Cite

Naeem, M., Tabassum, R., Khaskheli, M. S., Awan, A. H., Meraj, M. and Irfan, R. (2021) “Ondansetron for Prevention of Post-Operative Nausea and Vomiting (PONV) in General Surgery Patients”, Journal of Pharmaceutical Research International, 33(51B), pp. 35–39. doi: 10.9734/jpri/2021/v33i51B33508.